Efficacy and Safety of Nab-Paclitaxel Plus S-1 Compared With S-1 Plus Oxaliplatin in Advanced Gastric Cancer: A Systematic Review and Meta-analysis
- DOI
- 10.1097/mjt.0000000000002210
- Published
- 2026-09-09
- Container
- American Journal of Therapeutics
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/mjt.0000000000002210,
title = {Efficacy and Safety of Nab-Paclitaxel Plus S-1 Compared With S-1 Plus Oxaliplatin in Advanced Gastric Cancer: A Systematic Review and Meta-analysis},
author = {Ahmed Raza and Ali T. Khan and Faiza Fatima and Mavra Khan and Muhammad I. Bhatti and Umaima Cheema},
year = {2026},
journal = {American Journal of Therapeutics},
doi = {10.1097/mjt.0000000000002210},
url = {https://doi.org/10.1097/mjt.0000000000002210}
}RIS
TY - JOUR TI - Efficacy and Safety of Nab-Paclitaxel Plus S-1 Compared With S-1 Plus Oxaliplatin in Advanced Gastric Cancer: A Systematic Review and Meta-analysis AU - Ahmed Raza AU - Ali T. Khan AU - Faiza Fatima AU - Mavra Khan AU - Muhammad I. Bhatti AU - Umaima Cheema PY - 2026 JO - American Journal of Therapeutics DO - 10.1097/mjt.0000000000002210 UR - https://doi.org/10.1097/mjt.0000000000002210 ER -
APA
Raza, A., Khan, A. T., Fatima, F., Khan, M., Bhatti, M. I., & Cheema, U. (2026). Efficacy and Safety of Nab-Paclitaxel Plus S-1 Compared With S-1 Plus Oxaliplatin in Advanced Gastric Cancer: A Systematic Review and Meta-analysis. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0000000000002210
Source records
- crossref · retrieved 2026-09-27T11:06:42.404Z